{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:54:09Z","timestamp":1793091249429,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40121-021-00567-8","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T09:04:53Z","timestamp":1638867893000},"page":"389-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Meta-Regression of Herpes Zoster Incidence Worldwide"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4805-5118","authenticated-orcid":false,"given":"Andrea","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2879-2663","authenticated-orcid":false,"given":"Kyle","family":"Fahrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-964X","authenticated-orcid":false,"given":"Binod","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-3676","authenticated-orcid":false,"given":"Hilde","family":"Vroling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-0333","authenticated-orcid":false,"given":"D\u00e9sir\u00e9e","family":"van Oorschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-5810","authenticated-orcid":false,"given":"Barbara P.","family":"Yawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"1","key":"567_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40261-017-0581-5","volume":"38","author":"A Mizukami","year":"2018","unstructured":"Mizukami A, Sato K, Adachi K, et al. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 years or older: results from a prospective, observational cohort study. Clin Drug Investig. 2018;38(1):29\u201337.","journal-title":"Clin Drug Investig"},{"issue":"RR-5","key":"567_CR2","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1\u201330.","journal-title":"MMWR Recomm Rep"},{"key":"567_CR3","unstructured":"Centers for Disease Control and Prevention. Shingles (Herpes Zoster). 2018. https:\/\/www.cdc.gov\/shingles\/about\/index.html. Accessed July 12, 2021"},{"issue":"1","key":"567_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12877-017-0420-9","volume":"17","author":"L Varghese","year":"2017","unstructured":"Varghese L, Standaert B, Olivieri A, Curran D. The temporal impact of aging on the burden of herpes zoster. BMC Geriatr. 2017;17(1):30.","journal-title":"BMC Geriatr"},{"issue":"2","key":"567_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","volume":"63","author":"K Kawai","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63(2):221\u20136.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"567_CR6","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.","journal-title":"BMJ Open"},{"issue":"12","key":"567_CR7","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","volume":"92","author":"K Kawai","year":"2017","unstructured":"Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017;92(12):1806\u201321.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"567_CR8","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","volume":"17","author":"D van Oorschot","year":"2021","unstructured":"van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714\u201332.","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"567_CR9","doi-asserted-by":"publisher","first-page":"A666","DOI":"10.1016\/j.jval.2014.08.2459","volume":"17","author":"A Terlinden","year":"2014","unstructured":"Terlinden A, Varghese L, Curran D. Meta-regression on European zoster incidence. Value Health. 2014;17(7):A666\u20137.","journal-title":"Value Health"},{"issue":"12","key":"567_CR10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/jmv.21599","volume":"81","author":"N Toyama","year":"2009","unstructured":"Toyama N, Shiraki K, Members of the Society of the Miyazaki Prefecture D. Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009;81(12):2053\u20138.","journal-title":"J Med Virol"},{"key":"567_CR11","doi-asserted-by":"crossref","unstructured":"Welton NJ, Sutton AJ, Cooper N, Abrams KR, Ades AE. Evidence synthesis for decision making in healthcare. Sons JW. 2012.","DOI":"10.1002\/9781119942986"},{"issue":"4","key":"567_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/sim.1040","volume":"21","author":"HC van Houwelingen","year":"2002","unstructured":"van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(4):589\u2013624.","journal-title":"Stat Med"},{"key":"567_CR13","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions, version 5.0.0. 2008. www.cochrane-handbook.org. Accessed Aug 26, 2021","DOI":"10.1002\/9780470712184"},{"key":"567_CR14","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"issue":"7","key":"567_CR15","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, for the Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"8","key":"567_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748\u201353.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"567_CR17","doi-asserted-by":"publisher","first-page":"e1001420","DOI":"10.1371\/journal.pmed.1001420","volume":"10","author":"SM Langan","year":"2013","unstructured":"Langan SM, Smeeth L, Margolis DJ, Thomas SL. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med. 2013;10(4):e1001420.","journal-title":"PLoS Med"},{"issue":"Suppl 4","key":"567_CR18","first-page":"193","volume":"151","author":"J Schiffner-Rohe","year":"2010","unstructured":"Schiffner-Rohe J, Jow S, Lilie HM, K\u00f6ster I, Schubert I. Herpes zoster in Germany. A retrospective analyse of SHL data. MMW Fortschr Med. 2010;151(Suppl 4):193\u20137.","journal-title":"MMW Fortschr Med"},{"issue":"2","key":"567_CR19","doi-asserted-by":"publisher","first-page":"ofu049","DOI":"10.1093\/ofid\/ofu049","volume":"1","author":"JA Suaya","year":"2014","unstructured":"Suaya JA, Chen S-Y, Li Q, Burstin SJ, Levin MJ. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States. Open Forum Infect Dis. 2014;1(2):ofu049.","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"567_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annepidem.2005.12.002","volume":"16","author":"W Opstelten","year":"2006","unstructured":"Opstelten W, Van Essen GA, Schellevis F, Verheij TJM, Moons KGM. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006;16(9):692\u20135.","journal-title":"Ann Epidemiol"},{"issue":"5","key":"567_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJM, Stalman WAB, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19(5):471\u20135.","journal-title":"Fam Pract"},{"issue":"2","key":"567_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005\u20132009. J Infect. 2015;70(2):178\u201386.","journal-title":"J Infect"},{"issue":"6","key":"567_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2340\/00015555-0729","volume":"89","author":"J-S Jih","year":"2009","unstructured":"Jih J-S, Yi-Ju C, Lin M-W, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Adv Dermatol Venereol. 2009;89(6):612\u20136.","journal-title":"Adv Dermatol Venereol"},{"issue":"1","key":"567_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12879-016-1581-4","volume":"16","author":"G Rimseliene","year":"2016","unstructured":"Rimseliene G, Vainio K, Gibory M, Salamanca BV, Flem E. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway. BMC Infect Dis. 2016;16(1):254.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"567_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348.","journal-title":"J Stat Softw"},{"key":"567_CR26","unstructured":"Burnham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach, 2nd ed. Springer; 2002."},{"key":"567_CR27","unstructured":"Cook RD, Weisberg S. Residuals and influence in regression. Hall LCa; 1982."},{"issue":"43","key":"567_CR28","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","volume":"25","author":"V Di Legami","year":"2007","unstructured":"Di Legami V, Gianino MM, Atti MCD, et al. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine. 2007;25(43):7598\u2013604.","journal-title":"Vaccine"},{"issue":"1","key":"567_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12879-015-1170-y","volume":"15","author":"K Sundstr\u00f6m","year":"2015","unstructured":"Sundstr\u00f6m K, Weibull CE, S\u00f6derberg-L\u00f6fdal K, Bergstr\u00f6m T, Spar\u00e9n P, Arnheim-Dahlstr\u00f6m L. Incidence of herpes zoster and associated events including stroke\u2014a population-based cohort study. BMC Infect Dis. 2015;15(1):488.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"567_CR30","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.4161\/hv.29303","volume":"10","author":"G Krishnarajah","year":"2014","unstructured":"Krishnarajah G, Carroll C, Priest J, Arondekar B, Burstin S, Levin M. Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations. Hum Vaccin Immunother. 2014;10(8):2460\u20137.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"567_CR31","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1080\/21645515.2015.1016672","volume":"11","author":"Q Zhu","year":"2015","unstructured":"Zhu Q, Zheng H, Qu H, et al. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong. China Hum Vaccin Immunother. 2015;11(8):2113\u20138.","journal-title":"China Hum Vaccin Immunother."},{"issue":"4","key":"567_CR32","doi-asserted-by":"publisher","first-page":"e0152660","DOI":"10.1371\/journal.pone.0152660","volume":"11","author":"Y Li","year":"2016","unstructured":"Li Y, An Z, Yin D, et al. Disease burden due to herpes zoster among population aged \u2265 50 years old in China: a community based retrospective survey. PLoS ONE. 2016;11(4):e0152660.","journal-title":"PLoS ONE"},{"issue":"11","key":"567_CR33","first-page":"2632","volume":"14","author":"L Lu","year":"2018","unstructured":"Lu L, Suo L, Li J, Pang X. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China. Hum Vaccin Immunother. 2018;14(11):2632\u20135.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"567_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13555-018-0268-8","volume":"9","author":"S Imafuku","year":"2019","unstructured":"Imafuku S, Matsuki T, Mizukami A, et al. Burden of herpes zoster in the Japanese population with immunocompromised\/chronic disease conditions: results from a cohort study claims database from 2005\u20132014. Dermatology and Therapy. 2019;9(1):117\u201333.","journal-title":"Dermatology and Therapy"},{"issue":"10","key":"567_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2188\/jea.JE20140210","volume":"25","author":"Y Takao","year":"2015","unstructured":"Takao Y, Miyazaki Y, Okeda M, et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25(10):617\u201325.","journal-title":"J Epidemiol"},{"issue":"12","key":"567_CR36","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3346\/jkms.2014.29.12.1706","volume":"29","author":"YJ Kim","year":"2014","unstructured":"Kim YJ, Lee CN, Lim C-Y, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014;29(12):1706\u201310.","journal-title":"J Korean Med Sci"},{"issue":"13","key":"567_CR37","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1017\/S0950268814003653","volume":"143","author":"B Liu","year":"2015","unstructured":"Liu B, Heywood AE, Reekie J, et al. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study. Epidemiol Infect. 2015;143(13):2871\u201381.","journal-title":"Epidemiol Infect"},{"key":"567_CR38","unstructured":"Reid JS, Ah Wong B. Herpes zoster (shingles) at a large New Zealand general practice: incidence over 5 years. N Zeal Med J [Internet]. 2014; 127(1407):56\u201360. http:\/\/europepmc.org\/abstract\/MED\/25530332."},{"issue":"10","key":"567_CR39","first-page":"1071","volume":"69","author":"FE Harrell","year":"1985","unstructured":"Harrell FE, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep. 1985;69(10):1071\u20137.","journal-title":"Cancer Treat Rep"},{"issue":"43","key":"567_CR40","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1016\/j.vaccine.2019.09.028","volume":"37","author":"DO Willer","year":"2019","unstructured":"Willer DO, Oostvogels L, Cunningham AL, et al. Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry\/ethnicity: a post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials. Vaccine. 2019;37(43):6262\u20137.","journal-title":"Vaccine"},{"key":"567_CR41","doi-asserted-by":"crossref","unstructured":"Daniel Mullins C, Onwudiwe NC, Branco de Ara\u00fajo GT, et al. Guidance Document: Global Pharmacoeconomic Model Adaption Strategies. Value Health Reg Issues. 2014;5:7\u201313.","DOI":"10.1016\/j.vhri.2014.02.006"},{"key":"567_CR42","unstructured":"United Nations Department of Economic and Social Affairs. World population prospects, Standard projections. 2019. https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/. Accessed Aug 26, 2021"},{"key":"567_CR43","unstructured":"National Institute on Aging. Why population aging matters: a global perspective. 2017. WPAM.pdf (nih.gov). Accessed Aug 26, 2021"},{"issue":"33","key":"567_CR44","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1016\/j.vaccine.2018.07.005","volume":"36","author":"D Curran","year":"2018","unstructured":"Curran D, Patterson B, Varghese L, et al. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States. Vaccine. 2018;36(33):5037\u201345.","journal-title":"Vaccine"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-021-00567-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T12:42:27Z","timestamp":1644928947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-021-00567-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s40121-021-00567-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}